Entrada Therapeutics (TRDA) Q2 2026 Earnings

May 7Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-1.06
-0.85
-0.63
-0.42

Details

Expected EPS
-1.036712
Actual EPS
-0.95
Surprise EPS
0.09
Surprise Percent
+8.36%

Description

⁨Entrada Therapeutics⁩ (⁦TRDA⁩) has reported earnings of ⁦-0.95⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts